- Home
- ELEV vs BCG Comparison
ELEV vs BCG Comparison
Compare ELEV & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- BCG
- Stock Information
- Founded
- ELEV 2019
- BCG 2016
- Country
- ELEV United States
- BCG United States
- Employees
- ELEV N/A
- BCG N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- BCG
- Sector
- ELEV Health Care
- BCG
- Exchange
- ELEV Nasdaq
- BCG Nasdaq
- Market Cap
- ELEV 37.6M
- BCG 42.3M
- IPO Year
- ELEV 2021
- BCG N/A
- Fundamental
- Price
- ELEV $0.66
- BCG $2.50
- Analyst Decision
- ELEV Buy
- BCG
- Analyst Count
- ELEV 6
- BCG 0
- Target Price
- ELEV $7.20
- BCG N/A
- AVG Volume (30 Days)
- ELEV 4.3M
- BCG 544.1K
- Earning Date
- ELEV 03-05-2025
- BCG 02-26-2025
- Dividend Yield
- ELEV N/A
- BCG N/A
- EPS Growth
- ELEV N/A
- BCG N/A
- EPS
- ELEV N/A
- BCG N/A
- Revenue
- ELEV N/A
- BCG $161,721,000.00
- Revenue This Year
- ELEV N/A
- BCG N/A
- Revenue Next Year
- ELEV N/A
- BCG N/A
- P/E Ratio
- ELEV N/A
- BCG N/A
- Revenue Growth
- ELEV N/A
- BCG N/A
- 52 Week Low
- ELEV $0.50
- BCG $1.85
- 52 Week High
- ELEV $5.83
- BCG $16.61
- Technical
- Relative Strength Index (RSI)
- ELEV 48.99
- BCG N/A
- Support Level
- ELEV $0.65
- BCG N/A
- Resistance Level
- ELEV $0.98
- BCG N/A
- Average True Range (ATR)
- ELEV 0.12
- BCG 0.00
- MACD
- ELEV -0.01
- BCG 0.00
- Stochastic Oscillator
- ELEV 18.38
- BCG 0.00
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.
About BCG Binah Capital Group Inc. Common Stock
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.